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clinical application of β-blocker agents requires patient and disease
oriented approaches.
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Objectives: Recently it has been documented that the NLRP3
inflammasome plays a pivotal role in the inflammatory response
to tissue injury. The NLRP3 inflammasome is a large multimeric
danger-sensing platform that induces activation of the caspase-1 and
mediates the cleavage of inactive pro-IL-1β, among other proteins,
into its active form. We have shown that the activation of the NLRP3
inflammasome exacerbates myocardial ischemia/reperfusion (I/R)
injury in diabetic mice. Moreover, our group previously demonstrated
that INF-4E inhibits NLRP3, ATPase and caspase-1 activities in THP-1
cells. Here we test in an ex-vivo model whether INF-4E inhibiting
NLRP3 may positively affect I/R injury, post-ischemic cardiac function
and molecular response in the rat hearts.
Materials and methods: Isolated hearts from male Wistar rats
(bodyweight 450,550 g; n = 7) underwent perfusionwithout ischemia
(Sham) or I/R (30-min ischemia plus 20-min or 60 min reperfusion)
with and without IFN-4E treatment (50 M for 20-min before ischemia).
Coronary perfusion pressure and left ventricular pressure (LVP) were
monitored, and dP/dtmax assessed during the entire period of
perfusion. Biopsies obtained at the end of reperfusion were used for
Western blotting evaluations of NLRP3 and caspase-1 (apoptosis index)
levels/activities and for assessment of RISK pathway involvement. At
the end of 60 min reperfusion infarct size was measured with nitro-
blue-tetrazolium technique by an independent observer.
Results: In this preliminary study, the 20 min IFN-4E pre-ischemic
administration induced a significant reduction of infarct size and an
improvement in post-ischemic LVP recovery. Western blot analysis
demonstrated NLRP3 and caspase-1 activation by I/R procedure,
which were strongly attenuated after IFN-4E pre-treatment. More-
over, an important modulation of RISK kinase phosphorylation was
observed, though a clear-cut correlation between the reduction in
infarct size and phosphorylation of RISK kinases was not observed.
Conclusions: These preliminary results demonstrate that the IFN-
4E inhibits the formation of the NLRP3 inflammasome in the rat heart
and ameliorates the response to myocardial I/R injury, confirming the
ability of this drug to affect NLRP3 inflammasome complex activation.
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Objectives: The role of diet is of paramount importance in the
prevention and development of cardiovascular disease (CVD). A diet
high in saturated fat increases the risk of heart disease and stroke,
in particular it causes about 31% of coronary heart disease and 11%
of stroke worldwide. The Mediterranean diet is the symbol of the
Italian style and is considered able to reduce the burden of CVD, but
this protective alimentary modality is frequently neglected for
incorrect life style. Recently it has been suggested that “spread bio
oil” (SBO), an innovative food product, at hard fat phase, mainly
based on olive oil, may be beneficial, thus in the present study we
aimed to compare three different diets, standard, high fat and SBO
diet, in terms of cardiac response to the ischemia/reperfusion (I/R).
Materials and methods: Male mice were fed with standard diet
(SD), high fat (HF) or spread SBO diet for 4 weeks. Before, during and
at the end of these diets blood samples were collected and the
anthropometric parameters, such as body mass index (BMI), weight,
height and abdominal circumference, were evaluated. The hearts
of each group were randomly assigned to two different protocols:
only Tyrode perfusion (Sham) or I/R (30 min ischemia and 60 min
reperfusion), at the end of experiments the infarct size was evaluated
with nitro-blue tetrazolium techniques.
Results: While HF diet did not induce significant variations of
anthropometric parameters (BMI, weight, and abdominal circumfer-
ence), left ventricular weight resulted significantly higher in compar-
ison to SD animals. Also, the infarct size resulted higher in HF than in SD
hearts (infarct size 65 ± 5% and 43 ± 5%, respectively). Although, the
animals fed with SBO diet displayed a significant increase of abdominal
circumferencewith respect to SD only, surprisingly enough, their hearts
had a smaller infarct size (26 ± 6%) with respect to both SD and HF
animals.
Conclusions: These preliminary data suggest that the SBO increases
the resistance of heart to I/R challenge, despite partial modifications
of anthropometric parameters. To explain these preliminary results
further investigations and analyses of cardioprotective pathways are
necessary.
doi:10.1016/j.vph.2015.11.031
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Objectives: Obestatin (Obe), a 23-amino acid peptide derived
from preproghrelin, affects several neurometabolic and cardiac
physiological functions. A preconditioning-like effect of obestatin in
limiting apoptosis and ischemia/reperfusion (I/R) injury in both
isolated rat heart and cultured adult cardiomyocytes has been recently
demonstrated. We hypothesized an obestatin-postconditioning-like
cardioprotective effect via a nitrosative/oxidative mitochondrial
signaling (NO/ROS/PKCε/mitoKATP channel).
Materials and methods: Isolated hearts underwent the following
protocols: control group (I/R, 30 min global ischemia followed by
120 min reperfusion); Obe group (obestatin 75 nM, for 20 min imme-
diately after ischemia and 100 min reperfusion). Other hearts received
obestatin plus different antagonist of NO/ROS/PKCε/mitoKATP channel
pathway. Each inhibitor was given during the last 5 min of stabilization
and the initial 20 min reperfusion. Developed left ventricular pressure
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(dLVP) was monitored and infarct size was measured with nitro-blue
tetrazolium technique.
Results: The I/R damage was reduced by the administration of
Obe in early reperfusion. In particular, postconditioning with Obe
reduced infarct size from 61 ± 4% (control group) to 32 ± 6% (Obe
group) of LV mass. Post-ischemic cardiac dysfunction was avoided by
Obe-postconditioning (dLVP variation with respect to pre-ischemic
value: −41 ± 7 mm Hg in control group vs +2 ± 8 mm Hg in Obe
group, p b 0.05). These protective effects were abolished by antag-
onists of NO/ROS/PKCε/mitoKATP channel pathway. In fact the co-
infusion of Obe with PKCε antagonist (εV1-2, 0.1 μM) or nitric oxide
synthase inhibitor (L-NIO, 1 μM) abrogated the cardiac protection
(infarct size 66 ± 7% and 65 ± 11% of LV mass, and dLVP variation:
−44 ± 10 mm Hg and −55 ± 7 mm Hg, respectively). The ROS
scavenger N-acetylcysteine (NAC, 10 μM) and the mitoKATP channel
blocker 5-hydroxydecanoate (5-HD, 10 μM), demonstrated that Obe
protection was dependent on the opening of mitoKATP channels and
ROS signaling. In fact infarct size was 59 ± 4% of LV in Obe + NAC
and 73 ± 25% of LV in Obe + 5-HD (p = NS vs I/R control group).
Also dLVP recovery was blunted by NAC or 5-HD (dLVP variation:
−19 ± 8 mm Hg and −11 ± 9 mm Hg, respectively).
Conclusions: These results suggest a novel cardioprotective
role for Obe, which appears mainly due to a direct reduction of
post-ischemic myocardial damage and dysfunction. Intriguingly,
obestatin-postconditioning includes a redox/NO dependent signal-
ing. These data suggest a potential role for obestatin as innovative
pharmacological agent to counteract the development of reperfusion
injury.
doi:10.1016/j.vph.2015.11.032
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Objectives: Acetylation and deacetylation at specific lysine (K)
residues is mediated by histone acetylases (HATs) and deacetylases
(HDACs), respectively. HATs and HDACs act on both histone and
non-histone proteins, regulating various processes, including car-
diac impulse propagation. Aim of the present work was to estab-
lish whether the function of the Ca2+ ATPase SERCA2, one of the
major players in Ca2+ reuptake during excitation–contraction
coupling in cardiac myocytes (CMs), could be modulated by direct
K acetylation.
Materials and methods: HL-1 atrial mouse cells (donated by
Prof. Claycomb), zebrafish and Streptozotocin-induced diabetic rat
CMs were treated with the pan-inhibitor of class I and II HDACs
suberanilohydroxamic acid (SAHA) for 1.5 h. Evaluation of SERCA2
acetylation was analyzed by co-immunoprecipitation (Co-IP). SERCA2
activity was measured on microsomes by pyruvate/NADH coupled
reaction assay. SERCA2mutantswere obtained after cloningwild-type
and mutated sequences into the pCDNA3 vector and transfected
into HEK cells. Ca2+ transients in CMs (loading with Fluo3-AM, field
stimulation, 0.5 Hz) and in transfected HEK cells (loading with FLUO-4,
caffeine pulse) were recorded.
Results: Co-IP experiments performed on HL-1 cells demon-
strated a significant increase in the acetylation of SERCA2 after SAHA-
treatment (2.5 uM, n = 3). This was associated with an increase in
SERCA2 activity in microsomes obtained from HL-1 cells, after SAHA
exposure (n = 5). Accordingly, SAHA-treatment significantly short-
ened the Ca2+ reuptake time of adult zebrafish CMs. Further, SAHA
2.5 nM restored to control values the recovery time of Ca2+
transients decay in diabetic rat CMs. HDAC inhibition also improved
contraction parameters, such as fraction of shortening, and increased
pump activity in microsomes isolated from diabetic CMs (n = 2).
Notably, the K464, identified by bioinformatic tools as the most
probable acetylation site on human SERCA2a, was mutated into
glutamine (Q) or arginine (R) mimicking acetylation and deacetylation
respectively. Measurements of Ca2+ transients in HEK cells revealed
that the substitution of K464 with R significantly delayed the transient
recovery time, thus indicating that deacetylation has a negative impact
on SERCA2 function.
Conclusions: Our results indicate that SERCA2 function can be
improved by pro-acetylation interventions and that this mechanism
of regulation is conserved among species. Therefore, the present
work provides the basis to open the search for novel pharmacolog-
ical tools able to specifically improve SERCA2 activity in diseases
where its expression and/or function is impaired, such as diabetic
cardiomyopathy.
doi:10.1016/j.vph.2015.11.033
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Objectives: Apelin peptide is a ligand of the G protein coupled
receptor (GPCR) APJ. Apelin-13 (Ape) is the most active isoform on
the cardiovascular system, where it exerts positive inotropy and
vasodilation. It also mimics ischemic postconditioning (IPost) against
ischemia–reperfusion (I/R) injury. Protection is caused by NO after
phosphatidylinositol 3-kinase (PI3K)-Akt activation. Various GPCRs
activate PI3K-Akt via epidermal growth factor receptor (EGFR)
transactivation by ligand-dependent and -independent pathways,
the former due to the shedding of epidermal growth factor (EGF)-
like ligands by matrix metalloproteinase (MMP), the latter to the
non-receptor tyrosine kinase Src. We investigated the main steps of
the pathway of Ape-induced cardioprotection focusing the attention
on a possible role of EGFR transactivation.
Materials and methods: Rat hearts underwent 30 min of global
ischemia and 2 h of reperfusion. Left ventricular pressure (LVP) was
measured from a balloon in the left ventricle. After reperfusion
infarct size (IS) was measured. EGFR phosphorylation was assessed
on hearts undergone 10 min of reperfusion with western blot. These
inhibitors were used: GM6001 to prevent EGF-like shedding by
MMP, AG1478 to inhibit EGFR, PP2 to inhibit Src, LY294002, ODQ and
5HD to inhibit PI3K, guanylyl cyclase (GC) and mitochondrial ATP-
dependent K+ channels (K+mito) respectively.
Results: Global ischemia caused an increase in left ventricular
diastolic pressure (LVDP) to about 50 mm Hg. Ape limited (p b 0.001)
this increase to about 30 mm Hg. All inhibitors prevented this effect.
I/R reduced the recovery of developed LVP to about 35% only of
the baseline. The recovery was improved by Ape (75% of baseline
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